Tirofiban Injection, Solution
Product Images NDC 55150-430

The text appears to be a graph with the title "Proportion with Endpoint Composite Endpoint 180-Day Follow-Up" showing data for two treatment options (Heparin and Tirofiban Hydrochloride + Heparin) over a period of 180 days. The graph shows risk reduction percentages for each treatment option at different time points. The was able to extract some numerical data along with p-value statistics.*

This is a description of Tirofiban Hydrochloride Injection, which is prescribed for intravenous use under the direction of a physician. Each 100 mL contains 5 mg of Tirofiban hydrochloride, 900 mg of sodium chloride, 54 mg of sodium citrate dihydrate, and 3.2 mg of citric acid anhydrous, with water for injection. The pH of the solution may have been adjusted using hydrochloric acid and/or sodium hydroxide. The product should be stored between 15°C and 30°C (59°F to 86°F) and protected from light. Additional medication should not be added to the solution, and the bag should be discarded if minute leaks are found. It is manufactured by Eugia US LLC.*

This is a description of a medication called Tirofiban Hydrochloride Injection. It is a premixed injection that must be used intravenously with a calibrated infusion device. The medication comes in a 100mL single-dose container and each 100mL contains 5mg of Tirofiban hydrochloride. The usual dosage should be directed by a physician with no additional medication added. It must not be used if there are leaks and should not be stored below 15°C or above 30°C. This medication is manufactured by Eugia US LLC.*

This is a description of Tirofiban Hydrochloride Injection, which comes in a 100 mL single-dose container with 5 mg of Tirofiban hydrochloride, 900 mg of sodium chloride, 54 mg of sodium citrate dihydrate, 3.2 mg of citric acid anhydrous, and water for injection. The recommended dosage is intravenously as directed by a physician, and it is cautioned not to add supplementary medication. Careful disposal is required if minute leaks are found. The storage conditions dictate that it must be stored at 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F) and be shielded from light. The NDC code is 55150-429-01.*

This is a medication called Tirofiban Hydrochloride Injection, which is recommended for intravenous infusion through a calibrated infusion device. The medication comes in a single-dose container with pre-mixed iso-osmotic tirofiban hydrochloride equivalent to 12.5 mg, sodium chloride, sodium citrate dihydrate, citric acid anhydrous, and water for injection. Usual dosage instructions are given in the package insert, and it is cautioned not to add supplementary medication and to check for minute leaks, as sterility may be impaired. It is also recommended to store at 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F) and protect from light during storage. The manufacturer of this medication is Eugia US LLC.*

This is a prescription medicine called Tirofiban Hydrochloride Injection that comes in a 250 mL single-dose container with 12.5 mg per 250 mL (50 mcg/mL) solution for intravenous infusion. It is recommended for use with a calibrated infusion device and contains tirofiban hydrochloride, sodium chloride, sodium citrate dihydrate, citric acid anhydrous, and water for injection. The solution should not have any leaks and should be clear before use. It should be stored at controlled room temperature, protected from light, and discarded if unused. Dosage instructions should be followed as directed by a physician. The manufacturer is Eugia US LLC.*

This is a description of a drug called Tirofiban Hydrochloride Injection, which is packaged in a single-dose container of 250 mL. Each container contains 12.5 mg of Tirofiban hydrochloride, 2.25 g sodium chloride, 135 mg sodium citrate dihydrate, and 8 mg citric acid anhydrous dissolved in water for injection. This drug is administered intravenously and is recommended for use with a calibrated infusion device. The container should not be used if the solution is not clear or if there are minute leaks. The storage temperature should be between 15-30°C, and the drug should be protected from light during storage. The recommended dosage is as directed by a physician and the package insert should be reviewed before use.*